These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32684837)
1. Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy. Chen C; Tan L; Zhu W; Lei L; Kuang Y; Liu P; Li J; Chen X; Peng C Mediators Inflamm; 2020; 2020():8567320. PubMed ID: 32684837 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis. Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057 [TBL] [Abstract][Full Text] [Related]
3. Ze-Qi-Tang formula inhibits MDSCs glycolysis through the down-regulation of p21/Hif1α/Glut1 signal in psoriatic-like mice. Zhu Y; Chen X; Zou Y; Su L; Yan X; Zhu X; Hou Y; Liu M; Jiang W; Zou C; Chen X; Xu Z Phytomedicine; 2024 Jul; 130():155544. PubMed ID: 38810554 [TBL] [Abstract][Full Text] [Related]
4. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice. Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969 [TBL] [Abstract][Full Text] [Related]
5. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
6. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model. Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414 [TBL] [Abstract][Full Text] [Related]
8. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells. Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593 [TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms. Cao LY; Chung JS; Teshima T; Feigenbaum L; Cruz PD; Jacobe HT; Chong BF; Ariizumi K J Invest Dermatol; 2016 Sep; 136(9):1801-1810. PubMed ID: 27236103 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409 [TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis. Zhang J; Zhang Y; Yang Z; Cheng D; Zhang H; Wei L; Liu C; Yan F; Li C; Dong G; Wang C; Shi D; Xiong H Front Immunol; 2023; 14():1091541. PubMed ID: 36969174 [TBL] [Abstract][Full Text] [Related]
12. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells. Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537 [TBL] [Abstract][Full Text] [Related]
13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
14. Notch1 Signaling Regulates the Th17/Treg Immune Imbalance in Patients with Psoriasis Vulgaris. Ma L; Xue H; Gao T; Gao M; Zhang Y Mediators Inflamm; 2018; 2018():3069521. PubMed ID: 29686529 [TBL] [Abstract][Full Text] [Related]
15. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209 [TBL] [Abstract][Full Text] [Related]
16. Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells. Soler DC; Young AB; Fiessinger L; Galimberti F; Debanne S; Groft S; McCormick TS; Cooper KD J Invest Dermatol; 2016 Apr; 136(4):798-808. PubMed ID: 26807516 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure. Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117 [TBL] [Abstract][Full Text] [Related]
18. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3. Ma M; Huang W; Kong D Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056 [TBL] [Abstract][Full Text] [Related]
19. The vitamin D Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055 [TBL] [Abstract][Full Text] [Related]
20. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Lovato P; Norsgaard H; Tokura Y; Røpke MA J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]